Johnson & Johnson hit as jury awards ‘excessive’ $8 billion in damages

Shares of Johnson & Johnson dipped 2% on Wednesday after a jury awarded $8 billion in punitive damages to a man who accused the drugmaker of failing to warn that young men using its antipsychotic drug Risperdal could grow breasts. Reuters Health News

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.